This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Dec;56(12):1121-8.

doi: 10.1034/j.1398-9995.2001.00019.x.

Anti-IgE treatment: an update

K S Babu¹, S H Arshad, S T Holgate

Affiliations

PMID: 11736740
DOI: 10.1034/j.1398-9995.2001.00019.x

Review

Anti-IgE treatment: an update

K S Babu et al. Allergy. 2001 Dec.

. 2001 Dec;56(12):1121-8.

doi: 10.1034/j.1398-9995.2001.00019.x.

Authors

K S Babu¹, S H Arshad, S T Holgate

Affiliation

¹ Medical Specialties, Mail Point 810, Southampton General Hospital, Southampton SO16 6YD, UK.

PMID: 11736740
DOI: 10.1034/j.1398-9995.2001.00019.x

No abstract available

PubMed Disclaimer

Similar articles

[Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
Kupryś-Lipińska I, Kuna P. Kupryś-Lipińska I, et al. Pneumonol Alergol Pol. 2009;77(1):43-51. Pneumonol Alergol Pol. 2009. PMID: 19308909 Review. Polish.
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST, Djukanović R, Casale T, Bousquet J. Holgate ST, et al. Clin Exp Allergy. 2005 Apr;35(4):408-16. doi: 10.1111/j.1365-2222.2005.02191.x. Clin Exp Allergy. 2005. PMID: 15836747 Review.
Omalizumab in asthma: approval and postapproval experience.
Chiang DT, Clark J, Casale TB. Chiang DT, et al. Clin Rev Allergy Immunol. 2005 Aug;29(1):3-16. doi: 10.1385/CRIAI:29:1:003. Clin Rev Allergy Immunol. 2005. PMID: 16222080 Review.
Omalizumab and the treatment of allergic rhinitis.
Kaliner MA. Kaliner MA. Curr Allergy Asthma Rep. 2004 May;4(3):237-44. doi: 10.1007/s11882-004-0032-2. Curr Allergy Asthma Rep. 2004. PMID: 15056407 Review.
Anti-IgE therapy: clinical utility beyond asthma.
Casale TB, Stokes J. Casale TB, et al. J Allergy Clin Immunol. 2009 Apr;123(4):770-1.e1. doi: 10.1016/j.jaci.2009.02.016. J Allergy Clin Immunol. 2009. PMID: 19348915 No abstract available.

See all similar articles

Cited by

Omalizumab for asthma in adults and children.
Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Normansell R, et al. Cochrane Database Syst Rev. 2014 Jan 13;2014(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Cochrane Database Syst Rev. 2014. PMID: 24414989 Free PMC article.
Emerging therapeutic options for atopic dermatitis: beyond TIMs.
Conner ER, Beck LA. Conner ER, et al. Curr Allergy Asthma Rep. 2006 Jul;6(4):275-81. doi: 10.1007/s11882-006-0060-1. Curr Allergy Asthma Rep. 2006. PMID: 16822379 Review.
The immunoglobulin E receptor: expression and regulation.
Conner ER, Saini SS. Conner ER, et al. Curr Allergy Asthma Rep. 2005 May;5(3):191-6. doi: 10.1007/s11882-005-0037-5. Curr Allergy Asthma Rep. 2005. PMID: 15842956 Review.
Effect of Oreodoxa oleracea Jacq. pollen protein allergen in albino mice.
Ezikanyi DN, Oselebe H. Ezikanyi DN, et al. Postepy Dermatol Alergol. 2020 Aug;37(4):566-571. doi: 10.5114/ada.2020.98286. Epub 2020 Sep 2. Postepy Dermatol Alergol. 2020. PMID: 32994780 Free PMC article.
Mapping of the CD23 binding site on immunoglobulin E (IgE) and allosteric control of the IgE-Fc epsilonRI interaction.
Borthakur S, Hibbert RG, Pang MO, Yahya N, Bax HJ, Kao MW, Cooper AM, Beavil AJ, Sutton BJ, Gould HJ, McDonnell JM. Borthakur S, et al. J Biol Chem. 2012 Sep 7;287(37):31457-61. doi: 10.1074/jbc.C112.397059. Epub 2012 Jul 19. J Biol Chem. 2012. PMID: 22815482 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database